Global Blood Therapeutics Inc. (GBT) Dropped -7.56% or -3.48 To Price $42.48 On Thursday


Global Blood Therapeutics Inc. (GBT) dropped -7.56% or -3.48 to $42.48. It is near to 1.01 million shares traded, which is 130.73% compare to the average total volume 769504. The market cap of GBT is $2.21 billion. The year to date change is 2.89%. The 52 week price range is from $26.1 to $68.05. Price of GBT have changed 1.43% during last week. It have changed 1.77% over last month, -3.16% over last 3 months, -14.99% over last 6 months and 75.05% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GBT is 45.20. It is 6.40% above current price. The 200-day Moving Averages for GBT is 47.83. It is 12.59% above current price. The 52-week High is 68.05. It is 60.19% from the current price. The 52-week Low is 26.1. It is -38.56% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GBT is 7.6 on 2018-08-15. Short % to float is 13.93%. There are some statistics of GBT. It is has market cap $2.21 billion. The share outstanding is 52.05 million. The average volume is 769504. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GBT is -38.19%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GBT is -35.79%.


Tags:

Share this post